perfluorobutane has been researched along with Cancer of Pancreas in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, M; Honma, S; Imazu, H; Ito, M; Shimamoto, N; Sumiyama, K | 1 |
| Itonaga, M; Ueda, K; Yamashita, Y | 1 |
| Harima, H; Kaino, S; Kawano, M; Sakaida, I; Shinoda, S; Suenaga, S | 1 |
| Doisaki, M; Haruta, J; Hattori, S; Hayakawa, F; Ishikawa, T; Murate, K; Yama, T; Yamada, K; Yamaguchi, T; Yashika, J | 1 |
| Akimoto, Y; Horiguchi, S; Kato, H; Matsumoto, K; Mizukawa, S; Muro, S; Okada, H; Tomoda, T; Tsutsumi, K; Uchida, D; Yamamoto, N | 1 |
| Hideyuki, H; Michiko, Y; Yasuyuki, S; Yoshimitsu, Y | 1 |
| Ang, TL; Ikeda, K; Imazu, H; Kakutani, H; Matsunaga, K; Omar, S; Sasaki, Y; Sumiyama, K; Tajiri, H; Uchiyama, Y | 1 |
| Goto, H; Hiramatsu, T; Hirooka, Y; Ishigami, M; Ishikawa, T; Itoh, A; Itoh, Y; Kasugai, T; Katano, Y; Kawashima, H; Matsubara, H; Miyahara, R; Nakamura, M; Nakamura, Y; Ohmiya, N; Ohno, E | 1 |
| Ang, TL; Hino, S; Ikeda, K; Imazu, H; Kakutani, H; Kanazawa, K; Mori, N; Omar, S; Sumiyama, K; Tajiri, H | 1 |
| Higuchi, K; Imoto, A; Inoue, T; Kurisu, Y; Masuda, D; Ogura, T; Ohama, H; Takeuchi, T; Takii, M; Tokioka, S; Umegaki, E | 1 |
| Ichinose, M; Iguchi, M; Itonaga, M; Kato, J; Maeda, H; Maekita, T; Tamai, H; Ueda, K; Yamashita, Y; Yoshida, T | 1 |
| Andrén-Sandberg, A; Bach-Gansmo, T; Holtås, S; Wallengren, NO | 1 |
| Düx, M; Fink, C; Grenacher, L; Hansmann, HJ; Kauffmann, GW; Leipold, R; Richter, GM; Spielhaupter, E | 1 |
| Akasu, G; Fukuyo, K; Goto, Y; Kawahara, R; Kinoshita, H; Okuda, K; Sakai, T; Sato, T; Tanaka, H; Yasumoto, M | 1 |
14 other study(ies) available for perfluorobutane and Cancer of Pancreas
| Article | Year |
|---|---|
Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: In vivo mouse pancreatic ductal adenocarcinoma model.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Contrast Media; Deoxycytidine; Endosonography; Female; Ferric Compounds; Gemcitabine; Iron; Mice, Inbred C57BL; Microbubbles; Oxides; Pancreatic Neoplasms; Tumor Burden; Ultrasonic Therapy; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Real-time contrast-enhanced endoscopic ultrasonography-guided fine-needle aspiration (with video).
Topics: Aged, 80 and over; Carcinoma; Contrast Media; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Ferric Compounds; Humans; Image Enhancement; Iron; Lung Neoplasms; Male; Middle Aged; Oxides; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2013 |
Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Topics: Adenocarcinoma, Mucinous; Aged; Area Under Curve; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Contrast Media; Diagnosis, Differential; Endosonography; Female; Ferric Compounds; Humans; Iron; Male; Middle Aged; Multidetector Computed Tomography; Oxides; Pancreatic Ducts; Pancreatic Neoplasms; Predictive Value of Tests; Retrospective Studies; ROC Curve; Watchful Waiting | 2015 |
A case of mucinous cystic neoplasm of the pancreas misdiagnosed as a pancreatic pseudocyst at the initial exam and resected after a 2-year follow-up.
Topics: Adult; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Cystadenoma, Mucinous; Diagnosis, Differential; Diagnostic Errors; Endosonography; Female; Ferric Compounds; Follow-Up Studies; Humans; Iron; Neuroendocrine Tumors; Oxides; Pancreas; Pancreatic Neoplasms; Pancreatic Pseudocyst; Tomography, X-Ray Computed | 2015 |
Diagnosing Pancreatic Tumors Using Contrast-enhanced Harmonic Endoscopic Ultrasonography with Sonazoid.
Topics: Adult; Clinical Protocols; Contrast Media; Endosonography; Ferric Compounds; Humans; Iron; Oxides; Pancreatic Neoplasms; Young Adult | 2016 |
Education and Imaging. Gastrointestinal: contrast-enhanced harmonic EUS for pancreatic cancer.
Topics: Contrast Media; Endosonography; Fatal Outcome; Ferric Compounds; Humans; Iron; Male; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Oxides; Pancreatic Neoplasms; Predictive Value of Tests; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies.
Topics: Biliary Tract Neoplasms; Contrast Media; Diagnosis, Differential; Endosonography; Ferric Compounds; Follow-Up Studies; Humans; Injections, Intravenous; Iron; Neoplasm Staging; Oxides; Pancreatic Neoplasms; Pilot Projects; Preoperative Period; Prospective Studies; Reproducibility of Results | 2010 |
Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Autoimmune Diseases; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Endosonography; Female; Ferric Compounds; Humans; Iron; Japan; Male; Middle Aged; Oxides; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Retrospective Studies; ROC Curve; Time Factors | 2011 |
Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma.
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Carcinoma; Contrast Media; Diagnosis, Differential; Endosonography; Female; Ferric Compounds; Humans; Image Interpretation, Computer-Assisted; Iron; Male; Middle Aged; Oxides; Pancreatic Neoplasms; Pancreatitis; Retrospective Studies; ROC Curve; Signal Processing, Computer-Assisted; Time Factors | 2012 |
Splenic artery aneurysm masquerading as a pancreatic tumor--diagnosis by contrast-enhanced endoscopic ultrasound.
Topics: Aneurysm; Contrast Media; Diagnosis, Differential; Endosonography; Ferric Compounds; Humans; Iron; Male; Middle Aged; Oxides; Pancreatic Neoplasms; Splenic Artery; Tomography, X-Ray Computed | 2012 |
Usefulness of contrast-enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study.
Topics: Adenocarcinoma, Mucinous; Aged; Carcinoma, Papillary; Contrast Media; Diagnosis, Differential; Endosonography; Female; Ferric Compounds; Humans; Iron; Male; Oxides; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
MR imaging of the pancreas at 0.3 T using a super-paramagnetic oral contrast medium.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Ferric Compounds; Humans; Iron; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Pancreatic Neoplasms | 1994 |
[Prospective study to compare high-resolution computed tomography and magnetic resonance imaging in the detection of pancreatic neoplasms: use of intravenous and oral MR contrast media].
Topics: Administration, Oral; Biopsy; Contrast Media; Data Interpretation, Statistical; Female; Ferric Compounds; Gadolinium DTPA; Humans; Injections, Intravenous; Iron; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Pancreas; Pancreatic Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2001 |
Clinicopathological analysis of contrast-enhanced ultrasonography using perflubutane in pancreatic adenocarcinoma.
Topics: Actins; Adenocarcinoma; Adult; Aged; Antigens, CD34; Contrast Media; Disease-Free Survival; Female; Fluorocarbons; Humans; Hypoxia; Male; Microbubbles; Microcirculation; Middle Aged; Muscle, Smooth; Neoplasms; Pancreatic Neoplasms; Time Factors; Ultrasonography | 2012 |